TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+19.31%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$1.19B
AUM Growth
+$1.19B
(+74%)
Cap. Flow
+$604M
Cap. Flow
% of AUM
50.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$449M |
| 2 |
Nurix Therapeutics
NRIX
|
$189M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$34.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Relay Therapeutics
RLAY
$619M
| $449M | 37.75% |
+10,551,115
| New | +$449M |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $279M | 23.46% |
8,024,031
-1,000,000
| -11% | -$34.8M |
|
|
3
Nurix Therapeutics
NRIX
$714M
| $189M | 15.9% |
+5,422,549
| New | +$189M |
|
4
Pliant Therapeutics
PLRX
$101M
| $132M | 11.11% |
5,839,160
| – | – |
|
5
Voyager Therapeutics
VYGR
$186M
| $68.2M | 5.73% |
6,391,176
| – | – |
|
6
Fulcrum Therapeutics
FULC
$351M
| $47.3M | 3.97% |
5,962,202
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $24.9M | 2.09% |
3,048,780
| – | – |
|